Skip to main content
. 2021 Sep 18;13:101. doi: 10.1186/s13098-021-00717-5

Table 3.

Mean laboratory results during the study period—comparison between the two study groups (2866 participants)

Variable HbA1C variability (N = 632) No HbA1C variability (N = 2234) p value
Glucose level in the blood (mg/dl) 191 ± 41.0 150.2 ± 31.9 < 0.001
LDL level (mg/dl) 98.1 ± 24.6 90.8 ± 20.2 < 0.001
Triglyceride level (mg/dl) 185 ± 107.0 150.8 ± 65.0 < 0.001
HDL levels (mg/dl) 45.0 ± 10.5 47.4 ± 10.7 < 0.001
Nephropathy (by microalbumin/creatinine ratio) 65.3% (417) 47.0% (1051) < 0.001
HbA1C levels (mean value) 9.1 ± 1.2 7.4 ± 0.9 < 0.001
HbA1C levels (median) 8.9 ± 1.4 7.4 ± 0.9 < 0.001
HbA1C counts during study period 20.5 ± 6.8 21.09 ± 6.8 0.057